Wallace Richard John 4
4 · ImmunoGen, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Wallace Richard John
Director
Transactions
- Award
Deferred Share Unit
2022-06-15+15,000→ 102,326 totalExercise: $0.00→ Common Stock (15,000 underlying) - Award
Stock Option (right to buy)
2022-06-15$3.37/sh+44,000$148,280→ 44,000 totalExercise: $3.37Exp: 2032-06-15→ Common Stock (44,000 underlying)
Footnotes (4)
- [F1]The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
- [F2]The deferred share units vest ratably over a one-year period in quarterly increments beginning on 9/1/22, contingent upon the individual remaining a director as of each vesting date.
- [F3]The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
- [F4]Exercisable as to 11,000 shares on each of 9/1/22, 12/1/22, 3/1/23, and 6/1/23, contingent upon the individual remaining a director as of each vesting date.